Treatment of Antibody-Mediated Rejection (ABMR) With CarBel

NCT06918990 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

25

Enrollment

NIH

Sponsor class

Conditions

Kidney Transplant Rejection

Interventions

BIOLOGICAL: Carfilzomib
BIOLOGICAL: Belatacept

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)